CymaBay Therapeutics (CBAY) Short Interest Ratio & Short Volume → Exposed: 10 CENT Crypto to Explode May 20th? (From True Market Insiders) (Ad) Free CBAY Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSustainabilityTrends CymaBay Therapeutics Short Interest DataCurrent Short Interest5,850,000 sharesPrevious Short Interest8,370,000 sharesChange Vs. Previous Month-30.11%Dollar Volume Sold Short$188.31 millionShort Interest Ratio1.6 Days to CoverLast Record DateFebruary 29, 2024Outstanding Shares114,724,000 sharesPercentage of Shares Shorted5.10%Today's Trading Volume73 sharesAverage Trading Volume4,113,430 sharesToday's Volume Vs. Average0% Short Selling CymaBay Therapeutics ? Sign up to receive the latest short interest report for CymaBay Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCBAY Short Interest Over TimeCBAY Days to Cover Over TimeCBAY Percentage of Float Shorted Over Time Ad Crypto 101 MediaTech GIANT’s Plans to Revolutionize Crypto…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. CymaBay Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 2/29/20245,850,000 shares $188.31 million -30.1%N/A1.6 $32.19 2/15/20248,370,000 shares $269.51 million -10.0%N/A2.4 $32.20 1/31/20249,300,000 shares $218.64 million -7.7%N/A5.4 $23.51 1/15/202410,070,000 shares $239.26 million +2.4%N/A5.4 $23.76 12/31/20239,830,000 shares $232.18 million -11.0%N/A5.2 $23.62 12/15/202311,050,000 shares $243.43 million -8.8%N/A5.7 $22.03 Get the Latest News and Ratings for CBAY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for CymaBay Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/30/202312,120,000 shares $231.86 million +1.8%N/A5.9 $19.13 11/15/202311,910,000 shares $214.38 million +9.1%N/A5.3 $18.00 10/31/202310,920,000 shares $178.87 million +4.0%N/A4.8 $16.38 10/15/202310,500,000 shares $141.54 million +24.0%N/A5 $13.48 9/30/20238,470,000 shares $126.29 million -8.2%N/A4.1 $14.91 9/15/20239,230,000 shares $152.48 million +3.0%N/A3.9 $16.52 8/31/20238,960,000 shares $123.20 million -21.1%N/A3.7 $13.75 8/15/202311,350,000 shares $145.85 million -0.7%N/A6 $12.85 7/31/202311,430,000 shares $149.16 million -1.0%N/A6.2 $13.05 7/15/202311,540,000 shares $133.75 million -4.6%N/A6.3 $11.59 6/30/202312,100,000 shares $132.50 million +23.5%N/A6.4 $10.95 6/15/20239,800,000 shares $82.42 million +2.7%N/A6 $8.41 5/31/20239,540,000 shares $85.67 million -5.8%N/A6.3 $8.98 5/15/202310,130,000 shares $105.35 million -8.5%N/A6 $10.40 4/30/202311,070,000 shares $119.11 million +7.3%N/A6.8 $10.76 4/15/202310,320,000 shares $91.95 million +6.9%N/A5.7 $8.91 3/31/20239,650,000 shares $84.15 million +26.1%N/A5.6 $8.72 3/15/20237,650,000 shares $69.39 million +54.9%N/A4.7 $9.07 2/28/20234,940,000 shares $39.52 million +11.8%N/A3.6 $8.00 2/15/20234,420,000 shares $35.23 million -0.2%N/A3.5 $7.97 1/31/20234,430,000 shares $37.17 million +17.2%N/A4.1 $8.39 1/15/20233,780,000 shares $24.61 million +1.9%N/A4.5 $6.51 12/30/20223,710,000 shares $23.26 million +7.9%N/A6.2 $6.27 12/15/20223,440,000 shares $14.76 million +11.7%N/A7.4 $4.29 11/30/20223,080,000 shares $10.41 million +5.8%N/A8.2 $3.38 11/15/20222,910,000 shares $10.68 million +60.8%N/A8.2 $3.67 10/31/20221,810,000 shares $6.30 million +4.0%3.1%4.9 $3.48 10/15/20221,740,000 shares $5.78 million +10.1%2.9%4.1 $3.32 9/30/20221,580,000 shares $5.53 million +19.7%2.7%3.2 $3.50 9/15/20221,320,000 shares $5.40 million -27.1%2.2%2 $4.09 8/31/20221,810,000 shares $6.41 million -9.1%3.1%2.5 $3.54 8/15/20221,990,000 shares $8.06 million -36.2%3.4%2.7 $4.05 7/31/20223,120,000 shares $9.77 million -10.9%5.3%3.8 $3.13 7/15/20223,500,000 shares $11.87 million +51.5%5.9%4.2 $3.39Crypto Pioneer Says: “The last crypto bull market has begun.” (Ad)Right now, there’s over $6 trillion in potential investment money waiting on the sidelines. That means this crypto bull market has a lot more room to run before it comes close to being a bubble.Click here if you’d like to learn more about these five cryptos… 6/30/20222,310,000 shares $6.81 million -31.0%3.9%3 $2.95 6/15/20223,350,000 shares $6.47 million +17.5%5.7%4.5 $1.93 5/31/20222,850,000 shares $5.59 million -5.0%N/A5 $1.96 5/15/20223,000,000 shares $5.40 million +33.3%N/A5.8 $1.80 4/30/20222,250,000 shares $5.11 million +0.9%N/A4.8 $2.27 4/15/20222,230,000 shares $6.91 million -11.2%N/A5 $3.10 3/31/20222,510,000 shares $7.81 million +10.6%N/A5.7 $3.11 3/15/20222,270,000 shares $6.74 million +26.8%N/A5.1 $2.97 2/28/20221,790,000 shares $5.69 million +0.6%N/A4.2 $3.18 2/15/20221,780,000 shares $5.70 million +19.5%N/A3.6 $3.20 1/31/20221,490,000 shares $4.44 million -11.3%N/A2.7 $2.98 1/15/20221,680,000 shares $5.29 million -4.0%N/A3.1 $3.15 12/31/20211,750,000 shares $5.92 million -12.5%N/A3.6 $3.38 12/15/20212,000,000 shares $6.68 million +12.4%N/A3.9 $3.34 11/30/20211,780,000 shares $5.89 million -9.2%N/A3.6 $3.31 11/15/20211,960,000 shares $8.41 million -7.6%N/A4.5 $4.29 10/29/20212,120,000 shares $8.27 million -0.9%3.3%5.5 $3.90 10/15/20212,140,000 shares $8.58 million -0.5%3.3%5.4 $4.01 9/30/20212,150,000 shares $7.85 million -17.6%3.3%5 $3.65 9/15/20212,610,000 shares $9.92 million -5.4%4.1%5.7 $3.80 8/31/20212,760,000 shares $10.93 million -4.5%4.3%5.4 $3.96 8/13/20212,890,000 shares $10.49 million -10.0%4.5%4.4 $3.63 7/30/20213,210,000 shares $12.65 million -46.0%5.0%4.6 $3.94 7/15/20215,940,000 shares $25.01 million -22.4%9.2%8 $4.21 6/30/20217,650,000 shares $33.35 million -5.7%11.9%9.8 $4.36 6/15/20218,110,000 shares $39.66 million -3.9%12.6%10.1 $4.89 5/28/20218,440,000 shares $35.70 million +1.7%13.1%10.5 $4.23 5/14/20218,300,000 shares $34.15 million -1.0%12.9%9.4 $4.12 4/30/20218,380,000 shares $38.72 million -1.5%13.2%8.1 $4.62 4/15/20218,510,000 shares $36.25 million -1.4%N/A0 $4.26 3/31/20218,630,000 shares $37.97 million -6.2%13.5%7.5 $4.40 3/15/20219,200,000 shares $45.91 million +10.3%14.5%7.1 $4.99 2/26/20218,340,000 shares $40.53 million +22.3%13.1%6.6 $4.86 2/12/20216,820,000 shares $41.06 million +32.2%10.7%5.7 $6.02 1/29/20215,160,000 shares $28.59 million +31.3%8.3%4.7 $5.54 1/15/20213,930,000 shares $24.41 million -10.9%6.3%3.8 $6.21 12/31/20204,410,000 shares $25.93 million +8.1%7.1%4.3 $5.88 12/15/20204,080,000 shares $29.34 million -3.6%6.6%3.7 $7.19 11/30/20204,230,000 shares $31.56 million -0.9%6.8%3.5 $7.46 11/15/20204,270,000 shares $35.01 million -6.8%6.9%3.2 $8.20 10/30/20204,580,000 shares $40.26 million -23.2%9.8%3.1 $8.79 10/15/20205,960,000 shares $46.25 million -6.0%12.7%2 $7.76 9/30/20206,340,000 shares $45.90 million +5.5%13.5%1.7 $7.24 9/15/20206,010,000 shares $39.00 million -5.4%11.8%1.7 $6.49 8/31/20206,350,000 shares $41.08 million -8.4%12.5%1.8 $6.47 8/14/20206,930,000 shares $40.68 million -29.4%13.6%1.9 $5.87 7/31/20209,810,000 shares $34.83 million +22.6%14.8%1.8 $3.55 7/15/20208,000,000 shares $26.64 million -1.0%12.1%2 $3.33 6/30/20208,080,000 shares $28.20 million -0.4%12.2%2.5 $3.49 6/15/20208,110,000 shares $31.87 million -8.7%12.3%2.4 $3.93Crypto Pioneer Says: “The last crypto bull market has begun.” (Ad)Right now, there’s over $6 trillion in potential investment money waiting on the sidelines. That means this crypto bull market has a lot more room to run before it comes close to being a bubble.Click here if you’d like to learn more about these five cryptos… 5/29/20208,880,000 shares $32.90 million +5.6%13.4%2.7 $3.71 5/15/20208,410,000 shares $34.06 million +7.0%12.7%2.5 $4.05 4/30/20207,860,000 shares $14.31 million -3.1%12.6%4.9 $1.82 4/15/20208,110,000 shares $13.54 million -5.0%13.1%5.6 $1.67 3/31/20208,540,000 shares $14.18 million -9.2%13.8%5.7 $1.66 3/13/20209,406,300 shares $15.90 million +1.9%15.2%4.9 $1.69 2/28/20209,230,000 shares $12.55 million -1.0%14.9%5.7 $1.36 2/14/20209,320,000 shares $15.19 million +21.5%15.1%3.9 $1.63 1/31/20207,670,000 shares $12.27 million +7.0%12.6%3.5 $1.60 1/15/20207,170,000 shares $11.11 million +0.1%11.7%3.3 $1.55 12/31/20197,160,000 shares $13.60 million No Change11.7%3.4 $1.90 CBAY Short Interest - Frequently Asked Questions What is CymaBay Therapeutics' current short interest? Short interest is the volume of CymaBay Therapeutics shares that have been sold short but have not yet been closed out or covered. As of February 29th, investors have sold 5,850,000 shares of CBAY short. Learn More on CymaBay Therapeutics' current short interest. What is a good short interest ratio for CymaBay Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CBAY shares currently have a short interest ratio of 2.0. Learn More on CymaBay Therapeutics's short interest ratio. Which institutional investors are shorting CymaBay Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of CymaBay Therapeutics: Walleye Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is CymaBay Therapeutics' short interest increasing or decreasing? CymaBay Therapeutics saw a drop in short interest in the month of February. As of February 29th, there was short interest totaling 5,850,000 shares, a drop of 30.1% from the previous total of 8,370,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does CymaBay Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to CymaBay Therapeutics: Mirum Pharmaceuticals, Inc. (18.69%), Avid Bioservices, Inc. (18.68%), G1 Therapeutics, Inc. (6.87%), Rigel Pharmaceuticals, Inc. (3.22%), BeiGene, Ltd. (1.75%), BioMarin Pharmaceutical Inc. (1.97%), Viatris Inc. (3.61%), United Therapeutics Co. (9.14%), Sarepta Therapeutics, Inc. (6.94%), Dr. Reddy's Laboratories Limited (0.58%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.39 billion), General Motors ($3.88 billion), Super Micro Computer, Inc. ($3.51 billion), Charter Communications, Inc. ($3.22 billion), Occidental Petroleum Co. ($3.13 billion), Tractor Supply ($2.76 billion), Coinbase Global, Inc. ($2.63 billion), Suncor Energy Inc. ($2.48 billion), Moderna, Inc. ($2.04 billion), and Royal Caribbean Cruises Ltd. ($1.87 billion). View all of the most shorted stocks. What does it mean to sell short CymaBay Therapeutics stock? Short selling CBAY is an investing strategy that aims to generate trading profit from CymaBay Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against CymaBay Therapeutics? A short squeeze for CymaBay Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CBAY, which in turn drives the price of the stock up even further. How often is CymaBay Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CBAY, twice per month. The most recent reporting period available is February, 29 2024. More Short Interest Resources from MarketBeat Related Companies: MIRM Short Interest Data CDMO Short Interest Data GTHX Short Interest Data RIGL Short Interest Data BGNE Short Interest Data BMRN Short Interest Data VTRS Short Interest Data UTHR Short Interest Data SRPT Short Interest Data RDY Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CBAY) was last updated on 5/29/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaA once-in-a-century investment opportunityStansberry ResearchWrite this ticker symbol down…StocksToTradeYou won't believe what Citigroup just did to it's depositorsAmerican AlternativeMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceHe Is Giving Away BitcoinCrypto Swap ProfitsBill Clinton Backing Biden Replacement???The Freeport Society Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CymaBay Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.